Anal Sac Adenocarcinoma (AGASACA) in Dogs: Treatment, Costs, and Clinical Trials in 2026

By Brycen Levings | Editor: Tariq Shah · September 21, 2026

Apocrine gland anal sac adenocarcinoma is an aggressive tumor that often spreads to lymph nodes early and can send calcium levels dangerously high. But with surgery and modern multimodal care, many dogs live well beyond two years. This guide explains the disease, its costs, and the clinical trials expanding options in 2026.

An Aggressive Tumor With a Chemistry Problem

Apocrine gland anal sac adenocarcinoma — usually shortened to AGASACA — is a cancer that develops in the glands of a dog's anal sacs. It's a tumor with two distinct challenges: it tends to spread to the lymph nodes inside the pelvis early, sometimes before the primary tumor is even noticed, and in a significant share of dogs it drives blood calcium to dangerous levels. The encouraging news is that with surgery and modern multimodal treatment, many dogs do remarkably well, often living well beyond two years.

What Is AGASACA?

AGASACA arises from the apocrine glands of the anal sacs, small structures on either side of the anus. It's often found on a routine rectal exam as a firm mass, or discovered when a dog shows scooting, straining, or a perianal swelling. Importantly, about a quarter of affected dogs (reports range widely, roughly 16–53%) develop paraneoplastic hypercalcemia — high blood calcium caused by substances the tumor releases — which can make dogs drink and urinate excessively and, over time, harm the kidneys. Roughly half or more of dogs already have spread to the pelvic (iliosacral) lymph nodes at diagnosis.

Standard Treatment and What It Costs

Surgery is the mainstay: removing the primary tumor (anal sacculectomy) and, when the pelvic lymph nodes are involved, removing those as well, at roughly $3,000 to $6,000. Radiation therapy is frequently added for local control, especially when surgery can't fully clear the disease, at $4,000 to $8,000; hypofractionated (shorter) palliative protocols are also used. Chemotherapy (often carboplatin) or the targeted drug toceranib (Palladia) may be incorporated, though a clear survival benefit from chemotherapy hasn't been firmly established. Hypercalcemia is managed with IV fluids and, when needed, bisphosphonates. Staging (CT of the abdomen and pelvis) and specialist consultations add to the cost. The outlook is genuinely encouraging with treatment. Median survival across stages with surgery and adjuvant therapy commonly falls in the range of about 15 to 28 months, and dogs treated aggressively with surgery, radiation, and chemotherapy have averaged over 2.5 years in some cases. One study of toceranib reported an overall median survival around 827 days. Smaller tumors and those addressed before extensive spread do best — which is why early diagnosis and specialist care matter so much.

You're on the right path 🐾

2clinical trials enrolling now

Navigating an AGASACA diagnosis can feel overwhelming, but you don't have to do it alone. Check your dog’s eligibility for active university clinical trials today and see if they qualify for cutting-edge therapies.

Clinical Trials: What Is Being Studied

Targeted therapy with toceranib and next-generation kinase inhibitors is an active area, given the meaningful clinical benefit already seen in retrospective studies. Refined radiation protocols — including shorter, more convenient hypofractionated schedules — aim to improve local and lymph node control with fewer visits. Sentinel lymph node mapping seeks to identify exactly which nodes to treat. And immunotherapy approaches are being explored for this metastasis-prone tumor.

Who Qualifies for an AGASACA Trial?

Most trials require a confirmed diagnosis, staging that includes CT of the abdomen and pelvis to map lymph node involvement, and adequate organ function (with attention to calcium and kidney values). Some trials focus on dogs with lymph node metastasis or non-resectable disease; others enroll dogs after surgery for adjuvant therapy. Both newly diagnosed and recurrent cases are commonly represented.

How Trial Costs Compare to Standard Treatment

Fully funded trials typically cover the investigational therapy, trial-specific imaging, and specialist monitoring — an offset against surgery plus a radiation course. Because AGASACA so often involves the lymph nodes, access to trial-level staging and targeted therapy can be especially valuable. Pet Trial Finder checks your dog against all 2 Apocrine Gland Anal Sac Adenocarcinoma trials — plus the full database of 100+ trials across 39 cancer types — in a single application. Results in seconds, not days.

Back to Blog